Sign in

CIK 0001628171 · Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472029180
Phone
650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. GOLDSMITH MARK A −$20.8M See Remarks sold 28% of stake
  2. Kelsey Stephen Michael −$19.8M See Remarks sold 26% of stake
  3. Kim Lorence H. −$15.0M Director sold 100% of stake
  4. Cislini Jeff −$12.7M SVP & General Counsel sold 54% of stake
  5. Anders Jack −$7.5M Chief Financial Officer sold 25% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Borisy Alexis Director Grant or award +1,191 2,340,075
2026-06-18 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +3,127 3,127
2026-06-18 ANDERSON ELIZABETH M Director Grant or award +1,191 9,406
2026-06-18 ANDERSON ELIZABETH M Director Grant or award · Stock Option (Right to Buy) +3,127 3,127
2026-06-18 Horning Sandra Director Grant or award +1,191 97,765
2026-06-18 Horning Sandra Director Grant or award · Stock Option (Right to Buy) +3,127 3,127
2026-06-18 Clyburn Frank Director Grant or award +1,191 10,929
2026-06-18 Clyburn Frank Director Grant or award · Stock Option (Right to Buy) +3,127 3,127
2026-06-18 Patel Sushil Director Grant or award +1,191 24,281
2026-06-18 Patel Sushil Director Grant or award · Stock Option (Right to Buy) +3,127 3,127
2026-06-18 Borellini Flavia Director Grant or award +1,191 26,215
2026-06-18 Borellini Flavia Director Grant or award · Stock Option (Right to Buy) +3,127 3,127
2026-06-17 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +573 $40.74 $23K 155,220
2026-06-17 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +3,302 $29.80 $98K 158,522
2026-06-17 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +25,725 $26.50 $682K 184,247
2026-06-17 Horn Margaret A Chief Operating Officer Sale 10b5-1 −29,600 $160.12 $4.7M 154,647
2026-06-17 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −573 75,075
2026-06-17 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −3,302 71,750
2026-06-17 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −25,725 114,275
2026-06-16 Mancini Anthony See Remarks Sale −4,615 $156.12 $720K 49,975

Page 8 of 18 · 352 trades